New drug - Volibris
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Rosemary Cook is director of the Queen’s Nursing Institute
The final report of Lord Darzi's Next Stage Review of the NHS, published in June, is not one, but a ... Read more
The QNI's Nursing No 1 campaign aims to help community nurses who want to improve their health and f... Read more
The Queen's Nursing Institute (QNI) has announced the latest round of nurse-led projects to be suppo... Read more
As the publication of the final report from the NHS Next Stage ('Darzi') review approaches, early 'f... Read more
The interim report of the Darzi Review, 'Our NHS, Our Future', led to the announcement by the DoH of... Read more
When I first moved out of 'hands-on' clinical nursing it struck me that there is a moral high ground... Read more
It is not often that QNI staff gather in a London park on a freezing Monday morning for a walk. In f... Read more
'Entrepreneur' and 'enterprise' are much over-used words in primary care these days. Read more
The NHS Operating Framework for 2008/9 is unlikely to be anyone's idea of a riveting read, but it do... Read more
I am delighted to have been invited to write a column for Independent Nurse, as we move into the nex... Read more
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more